Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
ConclusionsGiven the expanding applications of immunotherapy in cancer management, clinicians should stay vigilant against the potential development of unusual but life-threatening immune-mediated toxicities.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Emergency Medicine | Genetics | Guillain-Barr Syndrome | Immunotherapy | Lumbar Puncture | Neurology | Pain | Pain Management | Sarcomas | Study | Synovial Sarcoma | Toxicology